Hepatitis C Market & Forecast, Hepatitis C Pipeline Drugs Sales & Forecast,

Renub Research www.renub.com

Hepatitis C Market & Forecast, Hepatitis C Pipeline Drugs Sales & Forecast, Clinical Trials - Global

Renub Researchwww.renub.com

Published: August, 2015 Copyright © 2015 Renub Research – All Rights Reserved


Table of Contents

1. Executive Summary

2. Hepatitis C Drugs – Market & Forecast

3. Hepatitis C – Approved Drugs Sales &

Forecast

3.1 Pegasys Sales & Forecast

3.2 Pegintron Sales & Forecast

3.3 Incivek Sales

3.4 Victrelis Sales & Forecast

3.5 Olysio Sales & Forecast


Continue (www.renub.com)

3.6 Sovaldi / Harvoni Sales & Forecast

3.7 HCV Franchise Sales & Forecast

3.8 Viekira Pak Sales & Forecast

4. Hepatitis C - Pipeline Drugs Sales

Forecast

4.1 Drug A of (Merck & Co. Inc.)

4.2 Drug B of (Merck & Co. Inc.)

4.3 Drug C of (Bristol-Myers Squibb)



5.Hepatitis C – Deals & Acquisitions

6.Hepatitis C – Company Wise Clinical Trials

Analysis

6.1 AbbVie – Clinical Trials

6.1.1 Phase III

6.1.2 Phase II

6.1.3 Phase I



6.2 Bristol-Myers Squibb (BMS) – Clinical

Trials

6.2.1 Phase III

6.2.2 Phase II

6.3 Gilead Sciences – Clinical Trials

6.3.1 Phase II

6.4 Merck & Co. Inc. – Clinical Trials

6.4.1 Phase IV

6.4.2 Phase III

6.4.3 Phase II


Continue (www.renub.com) 6.4.4 Phase I

6.5 Tibotec / Janssen Therapeutics – Clinical

Trials

6.5.1Phase IV

6.5.2Phase III

6.5.3Phase II

6.5.4Phase I


Order Form

Scan and e-mail this page to [email protected],

alternatively one can also write the Contact Information in

an e-mail and mail it. Else you can also fax this form to

+91-120-424-9780

Questions? Please call

+1-678-302-0700 (USA)

+91-120-421-9822 (India), ,+91-120-424-9780

or mail to [email protected]

mailto:[email protected]



Format

Report Title: Hepatitis C Market & Forecast, Hepatitis C Pipeline Drugs Sales & Forecast, Clinical Trials - Global

For More

Details:http://www.renub.com/hepatitis-c-market-and-forecast-hepatitis-c-pipeline-drugs-sales-and-forecast-clinical-trials-global-466-p.php

Single User (Email from Publisher)

Hard Copy (Mail Delivery)

CD – Rom (Mail Delivery)

Global Site License (Multiple User

License)

US$ 1290 US$ 1390 US$ 1440 US$ 2090


For ordering this report: Easy ways to place your order

Order online by Credit Card (Visa,

MasterCard, etc.):

http://www.renub.com/hepatitis-c-market-and-forec

ast-hepatitis-c-pipeline-drugs-sales-and-forecast-cli

nical-trials-global-466-p.php

http://www.renub.com/hepatitis-c-market-and-forecast-hepatitis-c-pipeline-drugs-sales-and-forecast-clinical-trials-global-466-p.php




Bank Details

Account Name: Renub Research

A/C No.: 109102000023296

Name of Bank: IDBI Bank Ltd.

Swift Code: IBKLINBB010

Bank Address: 4th Floor

Indian Red Cross Building

1 Red Cross Road

Opposite Parliament Street

New Delhi – 110001

India


Contact Information

First Name: Last Name: Email: Job Title: Company: Address: City: Postal/Zip Code: Country: Phone: Mobile: Fax: Report Format: Your message:


Order by Check

Please post the check accompanied by this form, to:

Company Address: Renub Research

1st Floor,

C-86, Sector-10

Noida - 201301

Uttar Pradesh

India

Phone: +91-120-421-9822, 424-9780

For free Sample copy report or to view any of our sample work please contact us at

[email protected] or call +91-120-421-9822 (India), +1-678-302-0700 (USA)


Documents

Hepatitis C Market & Forecast, Hepatitis C Pipeline Drugs Sales & Forecast,